AbbVie · 19 hours ago
Senior Scientist I, Biologics In Vitro Technologies
Worcester, MA
Full-time
Onsite
Senior Level, Lead/Staff
8+ years expAbbVie is a company focused on discovering and delivering innovative medicines that address serious health issues. They are seeking a Senior Scientist I in Biologics In Vitro Technologies to develop and execute research strategies for therapeutic antibody discovery, while collaborating with cross-functional teams and presenting findings at scientific conferences.
BiotechnologyFinanceHealthcarePharmaceuticalVenture CapitalFinancial ServicesHealth CareMedical
Responsibilities
We are seeking an accomplished scientist who will make substantial contributions to the conception, execution and communication of antibody discovery strategies in a highly collaborative environment
Implement novel selection strategies and build industry-leading libraries for discovery and screening of therapeutic candidates
Identify and solve technical problems independently, conceive and implement innovative research ideas
Leverage expertise to develop and implement research to gain a detailed mechanistic understanding of the molecular pharmacology of therapeutic molecules
Utilize computational skills independently and in partnership with AI/ML and Digital Transformation teams to amplify in vitro technology work and build into AbbVie’s AI/ML infrastructure
Provide project updates, analyses and advice to cross-functional teams and senior management
Present original work internally across departments and at internal and external scientific conferences; may author or co-author peer-reviewed scientific papers or patents
Ensure consistency and quality of technical reports
Ability to engage internal and external scientific leaders in collaborative research
Serve as a biologics lead for cross-functional teams, and contribute scientific insights into multiple projects across various therapeutic areas; recognized and sought out as an expert in discovery and engineering of therapeutic molecules
Qualification
Required
PhD, MS, or BS degree in Biochemistry, Biochemical engineering or related disciplines with typically 0-3 (PhD), 8+ (MS), or 10+ (BS) years of experience
Hands-on experience with in vitro antibody discovery display technologies (e.g., phage, yeast, mammalian)
Extensive experience and up-to-date knowledge in antibody engineering and optimization (e.g., humanization, Fc optimization) best practices
Antibody/ antibody fragment library design, construction
Strong molecular biology skills
Familiarity with sequence analysis tools (Geneious, PipeBio, GeneData)
Application of computational tools within in vitro workflows to advance efficiency
Experience with flow cytometry
Ability to explore and develop new approaches to further advance innovative in vitro discovery and screening technologies
Excellent organizational skills and the ability to manage multiple projects simultaneously
Team player with the ability to operate in a fast-paced multi-disciplinary environment with functional and therapeutic areas
Adaptability to rapid changes in project priorities and timelines
Keen ability to engage internal and external scientific leaders in collaborative research
Preferred
Recognized in the scientific community through a record of peer-reviewed publications and patents preferred
Highly developed leadership and communication skills
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
Labiotech UG
2026-02-07
Pharma Letter
2026-02-06
Company data provided by crunchbase